---
title: "Orion Corporation — Ownership Dossier"
canonical: https://whiteintel.dev/entity/c21701fb-c41c-4e71-bf02-8d5d0b3941c9
json: https://whiteintel.dev/api/public/dossier/c21701fb-c41c-4e71-bf02-8d5d0b3941c9
identifier: gb-coh:1999212-6
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Orion Corporation

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `gb-coh:1999212-6`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/c21701fb-c41c-4e71-bf02-8d5d0b3941c9  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/c21701fb-c41c-4e71-bf02-8d5d0b3941c9  

## Ownership & control

### Holdings / subsidiaries

- **ORION PHARMA (UK) LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/cc6dd995-fd9d-550f-8146-f8c6b8bed4d8

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Orion Corporation**. Human view: https://whiteintel.dev/entity/c21701fb-c41c-4e71-bf02-8d5d0b3941c9 · Structured JSON: https://whiteintel.dev/api/public/dossier/c21701fb-c41c-4e71-bf02-8d5d0b3941c9._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._